Literature DB >> 8536724

An autopsy study of systemic fungal infections in patients with hematologic malignancies.

M Jandrlić1, S Kalenić, B Labar, D Nemet, J Jakić-Razumović, M Mrsić, V Plecko, V Bogdanić.   

Abstract

The aim of this study was to determine the incidence of fungal infections detected on autopsy in a group of 40 patients with hematologic malignancies treated with intensive chemotherapy or bone marrow transplantation, and to evaluate the risk factors for fungal infections. A control group included 38 patients with nonhematologic diseases and without granulocytopenia but with at least one of the known risk factors for fungal infections. Standard histopathological and microbiological methods were used. A higher incidence of invasive fungal infections was found in patients with hematologic malignancies as compared to the control group (p < 0.01). The predominant causes of fungal infections were Candida albicans and Aspergillus spp. The incidence of fungal infections caused by Aspergillus was higher (p < 0.05) in patients with hematologic malignancies than in the control group. The independent risk factors for fungal infections were fungal colonization, number of antibiotics and duration of antibiotic therapy, duration of fever and skin rash. A higher proportion of fungal infections was diagnosed on autopsy than during the patients' life (p < 0.01).

Entities:  

Mesh:

Year:  1995        PMID: 8536724     DOI: 10.1007/bf01690991

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

1.  Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).

Authors:  B Labar; V Bogdanic; A Kastelan; M Vrtar; L Grgic-Markulin; B Balabanic-Kamauf; I Francetic; I Dobric; D Grgicevic; V Kerhin-Brkljacic
Journal:  Biomed Pharmacother       Date:  1986       Impact factor: 6.529

Review 2.  Severe adverse cutaneous reactions to drugs.

Authors:  J C Roujeau; R S Stern
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

Review 3.  Candidiasis.

Authors:  F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 4.  Laboratory detection of fungemia.

Authors:  D J Geha; G D Roberts
Journal:  Clin Lab Med       Date:  1994-03       Impact factor: 1.935

Review 5.  Blood cultures and immunocompromised patients.

Authors:  C W Stratton
Journal:  Clin Lab Med       Date:  1994-03       Impact factor: 1.935

6.  Epidemiology of invasive fungal infections in bone marrow transplantation. EORTC Invasive Fungal Infections Cooperative Group.

Authors:  R De Bock
Journal:  Bone Marrow Transplant       Date:  1994       Impact factor: 5.483

7.  Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies.

Authors:  E Rintala
Journal:  Scand J Infect Dis       Date:  1994

8.  Fungemia in patients with leukemia.

Authors:  P Martino; C Girmenia; A Micozzi; R Raccah; G Gentile; M Venditti; F Mandelli
Journal:  Am J Med Sci       Date:  1993-10       Impact factor: 2.378

9.  Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections.

Authors:  J D Pirsch; D G Maki
Journal:  Ann Intern Med       Date:  1986-05       Impact factor: 25.391

10.  Environmental sampling for aspergilli during building construction on a hospital site.

Authors:  J M Goodley; Y M Clayton; R J Hay
Journal:  J Hosp Infect       Date:  1994-01       Impact factor: 3.926

View more
  4 in total

1.  Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates.

Authors:  P Steffan; J A Vazquez; D Boikov; C Xu; J D Sobel; R A Akins
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

Review 2.  Clinical and laboratory diagnosis of invasive candida infection in neutropenic patients.

Authors:  M Kalin; B Petrini
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

3.  Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors.

Authors:  S Kalenic; M Jandrlic; V Vegar; N Zuech; A Sekulic; E Mlinaric-Missoni
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?

Authors:  Sarah P Georgiadou; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2012-05-09       Impact factor: 6.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.